Researchers analyzed data of all cancer patients in Denmark between 1995 and 2009, approximately 426,000 patients. Of those patients, approximately 42,000 were diagnosed with diabetes before they were diagnosed with cancer.
Male cancer patients who were diagnosed with diabetes for at least two years and were treated with insulin had a 3.7 times higher mortality rate one year after cancer diagnosis than non-diabetic male cancer patients. Female patients had a 4.4 times higher mortality rate than non-diabetic female patients.
Researchers suggest the higher mortality risk may be linked to the increased burden of comorbidity, a delayed cancer diagnosis due to masked symptoms or an effect of insulin lowering glucose levels and producing a more aggressive cancer, according to the report.
More Articles on Cancer Care:
Socioeconomic Status Correlates With Cancer Mortality Rates
Cancer Treatment in Outpatient Setting Reduces Cost, Maintains Clinical Quality
Scripps Health Opens Proton Therapy Center for Cancer Care
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
